CONTEXTVISION AB (CONTX.OL) Stock Price, Forecast & Analysis

Europe Euronext Oslo OSL:CONTX • SE0014731154

3.7 NOK
-0.06 (-1.6%)
Last: Feb 5, 2026, 03:57 PM

CONTX.OL Key Statistics, Chart & Performance

Key Statistics
Market Cap286.27M
Revenue(TTM)112.76M
Net Income(TTM)3.58M
Shares77.37M
Float27.82M
52 Week High6.6
52 Week Low3.2
Yearly Dividend0
Dividend Yield4.18%
EPS(TTM)0.05
PE74
Fwd PE30.3
Earnings (Next)02-19
IPO1997-03-06
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Technology
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Technology
CONTX.OL short term performance overview.The bars show the price performance of CONTX.OL in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -5 -10 -15

CONTX.OL long term performance overview.The bars show the price performance of CONTX.OL in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40 -50

The current stock price of CONTX.OL is 3.7 NOK. In the past month the price decreased by -4.57%. In the past year, price decreased by -29.06%.

CONTEXTVISION AB / CONTX Daily stock chart

CONTX.OL Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to CONTX.OL. When comparing the yearly performance of all stocks, CONTX.OL is a bad performer in the overall market: 86.86% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

CONTX.OL Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to CONTX.OL. While CONTX.OL belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CONTX.OL Financial Highlights

Over the last trailing twelve months CONTX.OL reported a non-GAAP Earnings per Share(EPS) of 0.05. The EPS decreased by -83.7% compared to the year before.


Industry RankSector Rank
PM (TTM) 3.17%
ROA 3.07%
ROE 3.95%
Debt/Equity 0.07
Chartmill High Growth Momentum
EPS Q2Q%-100%
Sales Q2Q%-21.24%
EPS 1Y (TTM)-83.7%
Revenue 1Y (TTM)-13.08%

CONTX.OL Forecast & Estimates

7 analysts have analysed CONTX.OL and the average price target is 4.08 NOK. This implies a price increase of 10.27% is expected in the next year compared to the current price of 3.7.

For the next year, analysts expect an EPS growth of -103.45% and a revenue growth -17.19% for CONTX.OL


Analysts
Analysts40
Price Target4.08 (10.27%)
EPS Next Y-103.45%
Revenue Next Year-17.19%

CONTX.OL Ownership

Ownership
Inst Owners6.92%
Ins Owners24%
Short Float %N/A
Short RatioN/A

About CONTX.OL

Company Profile

CONTX logo image ContextVision AB operates as a medical technology software company that specializes in image analysis and artificial intelligence. The company is headquartered in Stockholm, Stockholm and currently employs 44 full-time employees. The firm is engaged in the image enhancement market and is a partner to the manufacturers of ultrasound, X-ray and Magnetic Resonance Imaging (MRI) equipment around the world. The firm develops software products, based on proprietary technology and artificial intelligence for image-based applications. ContextVision’s cutting-edge technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnosis and treatment. The firm operates through two separate segments: the Business Unit Medical Imaging and the Business Unit Digital Pathology. ContextVision has two subsidiaries: Inify Laboratories AB og ContextVision Inc.

Company Info

CONTEXTVISION AB

Hollandargatan 13, 2 tr

Stockholm STOCKHOLM SE

Employees: 42

CONTX Company Website

CONTX Investor Relations

Phone: 4687503550

CONTEXTVISION AB / CONTX.OL FAQ

What does CONTEXTVISION AB do?

ContextVision AB operates as a medical technology software company that specializes in image analysis and artificial intelligence. The company is headquartered in Stockholm, Stockholm and currently employs 44 full-time employees. The firm is engaged in the image enhancement market and is a partner to the manufacturers of ultrasound, X-ray and Magnetic Resonance Imaging (MRI) equipment around the world. The firm develops software products, based on proprietary technology and artificial intelligence for image-based applications. ContextVision’s cutting-edge technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnosis and treatment. The firm operates through two separate segments: the Business Unit Medical Imaging and the Business Unit Digital Pathology. ContextVision has two subsidiaries: Inify Laboratories AB og ContextVision Inc.


What is the current price of CONTX stock?

The current stock price of CONTX.OL is 3.7 NOK. The price decreased by -1.6% in the last trading session.


Does CONTX stock pay dividends?

CONTEXTVISION AB (CONTX.OL) has a dividend yield of 4.18%. The yearly dividend amount is currently 0.


What is the ChartMill technical and fundamental rating of CONTX stock?

CONTX.OL has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


Would investing in CONTEXTVISION AB be a good decision?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on CONTX.OL.


What is the market capitalization of CONTX stock?

CONTEXTVISION AB (CONTX.OL) has a market capitalization of 286.27M NOK. This makes CONTX.OL a Micro Cap stock.